Hildegrund C J Ertl (Hildegund C J Ertl)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Hydrogen Peroxide

Top Venues

Veterinary sciences

Human gene therapy

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Jan C Klapwijk, Alberto Del Rio Espinola, Silvana Libertini, Philippe Collin, Mick D Fellows, Susan Jobling, Anthony M Lynch, HansJoerg Martus, Catherine Vickers, Andreas Zeller, Luca Biasco, Martijn H Brugman, Frederic D Bushmann, Toni Cathomen, Hildegrund C J Ertl, Richard Gabriel, Guangping Gao, Julie K Jadlowsky, Ian Kimber, Thomas A Lanz, Bruce L Levine, Kenneth P Micklethwaite, Masafumi Onodera, Daniella M Pizzurro, Simon Reed, Michael Rothe, Denise E Sabatino, Jesse J Salk, Axel Schambach, Michael Themis, Jing Yuan
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article. Human gene therapy 35 (15-16) (2024)
Hildegrund C J Ertl
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs 83 (4) (2023)
Hildegrund C J Ertl
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs 83 (4) (2023)
Hildegrund C J Ertl
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs (2023)
Hildegrund C J Ertl
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs 83 (4) (2023)
Zhiquan Xiang, Klaudia Kuranda, William Quinn, Areski Chekaoui, Robert Ambrose, Mohadeseh Hasanpourghai, Mikhail Novikov, Dakota Newman, Christina Cole, Xiangyang Zhou, Federico Mingozzi, Hildegrund C J Ertl
The Effect of Rapamycin and Ibrutinib on Antibody Responses to Adeno-Associated Virus Vector-Mediated Gene Transfer. Human gene therapy 33 (11-12) (2022)
Arezki Chekaoui, Hildegrund C J Ertl
PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy. Cancer research 81 (17) (2021)
Mohadeseh Hasanpourghadi, Mikhail Novikov, Dakota Newman, ZhiQuan Xiang, Xiang Yang Zhou, Colin Magowan, Hildegrund C J Ertl
Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection. Virology journal 18 (1) (2021)
Charles E Rupprecht, Zhiquan Xiang, Alexandre Servat, Richard Franka, Jordona Kirby, Hildegrund C J Ertl
Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. Veterinary sciences 5 (2) (2018)
Divyansh Agarwal, Kenneth E Schmader, Andrew V Kossenkov, Susan Doyle, Raj Kurupati, Hildegrund C J Ertl
Immune response to influenza vaccination in the elderly is altered by chronic medication use. Immunity & ageing : I & A 15 (2018)
Charles E Rupprecht, Zhiquan Xiang, Alexandre Servat, Richard Franka, Jordona Kirby, Hildegrund C J Ertl
Erratum: Rupprecht, C.E., et al. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. Vet. Sci. 2018, 5, 59. Veterinary sciences 5 (3) (2018)
Raj K Kurupati, Xiangyang Zhou, Zhiquan Xiang, Lorraine H Keller, Hildegrund C J Ertl
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma. Cancer immunology, immunotherapy : CII 67 (10) (2018)